Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.4496
Delayed Data
As of Jun 24
 -0.0067 / -1.47%
Today’s Change
0.21
Today|||52-Week Range
0.60
+6.97%
Year-to-Date
7 Biotech Stocks that are Buys Right Now
Jun 17 / Zacks.com - Paid Partner Content
Mast Therapeutics (MSTX) Shares March Higher, Can It Continue?
Jun 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.46
Today’s open0.42
Day’s range0.42 - 0.46
Volume3,304,002
Average volume (3 months)2,108,819
Market cap$86.7M
Dividend yield--
Data as of 4:06pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-8.70%
Earnings growth (this year)+11.00%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
OHRPOHR Pharmaceutical I...+0.01+0.36%
GTXIGTX Inc+0.02+3.33%
--Innovative Pharmaceu...+0.00+3.45%
ABEOAbeona Therapeutics ...-0.15-5.54%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$39.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
Chief Financial Officer, CAO &
Senior VP
Brandi L. Roberts
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs